Kromek Group (AIM:KMK) has delivered the third milestone under its enablement agreement with Siemens Healthineers, triggering a $2.5m payment instalment.
The AIM-listed group, which develops radiation and bio-detection technology for advanced imaging and CBRN (chemical, biological, radiological and nuclear) detection markets, has now received $32.5m in total under the agreement.otent
A final $5m payment is due on completion of Kromek's delivery obligations, expected in the financial year to 30 April 2029.
The next payment trigger is the fourth and final milestone, tied to completion of delivery under the agreement by the 2029 financial year.
News Intelligence what this means for the company
Kromek has collected the third $2.5m instalment under its Siemens Healthineers enablement agreement, bringing total receipts to $32.5m with $5m due on final delivery by April 2029. The milestone is on track and de-risks near-term cash flow, but represents execution of a deal already announced and priced into the stock; the company remains dependent on hitting the fourth and final milestone nearly three years away.
The payment confirms Kromek is meeting contractual obligations to Siemens Healthineers and has now captured 87% of the total $37.5m agreement value. However, the remaining $5m is contingent on delivery completion by April 2029—a material execution risk over a multi-year horizon that the market has p already factored in.
Insights assembled by AI. Editor-reviewed and grounded in tickstock’s coverage and proprietary knowledge graph.
Content is for informational purposes only, not financial advice.
